- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Catalent Completes Expansion of Clinical Supply Facility in Shanghai | ||
| Fr | CordenPharma Joins Science Based Targets Initiative | ||
| Fr | Reaction Biology Acquires Bioassay GmbH and PSL | ||
| Do | Prince Sterilization Services Receives NJMEP Manufacturer of the Year Award | ||
| Do | AbCellera, Rallybio Enter Strategic Antibody Alliance for Rare Diseases | ||
| Do | Charles River Launches Endosafe Nexus 200 | ||
| Do | Faron Names Dr. Maija Hollmén as Chief Scientific Officer | ||
| Do | Ferring\'s First-in-Class Microbiota-Based Live Biotherapeutic Approved | ||
| Do | Ferring Wins FDA Approval of First-in-Class Microbiota-Based Live Biotherapeutic | ||
| Do | BioVaxys Successfully Completes Sterile Test-Run for Ovarian Cancer Vax | ||
| Do | Roivant Sciences, Pfizer Form Vant to Develop & Commercialize RVT-3101 | ||
| Do | August Bioservices Secures $65M in Funding to Expand Capacity | ||
| Mi | WuXi STA Launches New Parenteral Formulation Manufacturing Line | ||
| Mi | Recipharm Invests in Single Dose Nasal Platform Capabilities | ||
| Mi | Frontage Central Labs Awarded CAP Accreditation | ||
| Mi | Incannex Engages Eurofins to Manufacture Topical Therapeutic ReneCann | ||
| Mi | BioNTech and Ryvu Therapeutics Enter Multi-Target Research Collaboration | ||
| Mi | Experic Closes $14 Million Series B Capitalization | ||
| Di | Avectas Expands Collaboration with CCRM and OmniaBio Inc. | ||
| Di | Andelyn Biosciences to Bring First Gene Therapy for Treatment of INAD to Clinical Trials | ||
| Di | Quotient Sciences Partners with Emplicure to Manufacture and Study EMPLI03 | ||
| Di | AstraZeneca to Acquire Neogene Therapeutics in $320M Deal | ||
| Di | Biocon Completes Acquisition of Viatris\' Global Biosimilars Business | ||
| Di | BigHat Biosciences, Merck Enter AI Research Collaboration | ||
| Di | Immutep Enters Clinical Trial Collaboration Merck KGaA and Pfizer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
